-
T286636-25mgPotent Chk1 inhibitor.
-
T286636-50mgPotent Chk1 inhibitor.
-
T286636-5mgPotent Chk1 inhibitor.
-
T287170-10mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM.
-
T287170-1mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM.
-
T287170-25mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM.
-
T287170-50mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM.
-
T287170-5mgTCS 2314 (compound 3) is a selective very late antigen-4 (VLA-4, α4β1, CD49d/CD29) antagonist with an IC50 of 4.4 nM.
-
T288751-100mgSelective inhibitor of PTP1B.
-
T288751-10mgSelective inhibitor of PTP1B.
-
T288751-25mgSelective inhibitor of PTP1B.
-
T288751-50mgSelective inhibitor of PTP1B.